treatment options

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

Study Overview This study aimed to evaluate the efficacy and safety of MLC901 (NeuroAiDTMII) as a treatment for cognitive impairment

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury Read Post »

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients

Study Overview This study focuses on evaluating the effectiveness and safety of intrathecal pemetrexed in addressing leptomeningeal metastasis specifically in

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients Read Post »

Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods

Study Overview The ADEPT trial is designed to investigate the effectiveness of accelerated intermittent theta burst stimulation (iTBS) as a

Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods Read Post »

Scroll to Top